Award

National Institute of Allergy and Infectious Diseases 5K01AI168445-05

Development and testing of RSV vaccines using a computational framework of virus-host interaction

Recipient

University of Rochester, Rochester, NY, United States

Award Amount

$101,672.00

Ceiling

$101,672.00

Awarded

January 27, 2026

Identifier

5K01AI168445-05

A research project funded by NIAID to develop and test polyvalent RSV vaccines using computational models to evaluate immune responses and protective efficacy in mice.

Description

This project aims to develop and test polyvalent RSV vaccines using a computational framework of virus-host interaction. The study will evaluate the immune response to different vaccine formulations, including monovalent and polyvalent, in mice and assess their protective efficacy against RSV disease.

View original record